Stemline Therapeutics, Inc. (STML)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
10.88-0.36 (-3.20%)
At close: 4:00 PM EDT
People also watch:
VSTMOMEDEPZMTGTXXLRN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open11.19
Prev Close11.24
Bid0.00 x
Ask11.44 x 500
Day's Range10.76 - 11.29
52wk Range3.88 - 11.29
1y Target EstN/A
Market Cap208.01M
P/E Ratio (ttm)-5.08
Beta0.46
Volume230,264
Avg Vol (3m)137,445
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • GlobeNewswire6 days ago

    Stemline Therapeutics to Present at the Ladenburg Thalmann 2016 Healthcare Conference

    NEW YORK, Sept. 23, 2016-- Stemline Therapeutics, Inc. announced today that Ivan Bergstein, M.D., Stemline’ s CEO, will present at the Ladenburg Thalmann 2016 Healthcare Conference on Tuesday, September ...

  • GlobeNewswire22 days ago

    Stemline Therapeutics to Present at the Rodman & Renshaw 18th Annual Global Investment Conference

    NEW YORK, Sept. 07, 2016-- Stemline Therapeutics, Inc. announced today that Ivan Bergstein, M.D., Stemline’ s CEO, will present at the Rodman & Renshaw 18 th Annual Global Investment conference on Monday, ...

  • S&P, Nasdaq back off highs as oil surges
    Yahoo Financelast month

    S&P, Nasdaq back off highs as oil surges

    Catch The Final Round with Jen Rogers and markets correspondent Nicole Sinclair. Stocks in the green today include Stemline Therapeutics after the FDA granted Breakthrough status for its acute myeloid leukemia treatment, software maker Tableau as it appointed former Amazon exec Adam Selipsky as its new CEO, and Monsanto – shares of the seed and chemical-maker growing after Bloomberg reported Bayer and Monsanto were working on an improved takeover bid. Hillary Clinton’s presidential campaign has been dogged by accusations that wealthy Clinton Foundation donors sought favors from the State Department when Clinton was at its head.